Lord, Abbett & Co
HOLX

Lord, Abbett & Co’s Hologic HOLX Stock Holding History

Lord, Abbett & Co’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-74,700
Closed -$2.97M – 850
2018
Q2 		$2.97M Sell
74,700
-55,900
-43% -$2.15M 0.01% 803
2018
Q1 		$4.88M Sell
130,600
-31,200
-19% -$1.26M 0.01% 731
2017
Q4 		$6.92M Sell
161,800
-700
-0.4% -$27.9K 0.02% 696
2017
Q3 		$5.96M Sell
162,500
-270,216
-62% -$10.9M 0.02% 734
2017
Q2 		$19.6M Buy
432,716
+190,714
+79% +$8.42M 0.06% 456
2017
Q1 		$10.3M Buy
242,002
+154,018
+175% +$6.28M 0.03% 595
2016
Q4 		$3.53M Buy
+87,984
New +$3.4M 0.01% 796
2013
Q4 		– Sell
-1,231,122
Closed -$25.4M – 1066
2013
Q3 		$25.4M Sell
1,231,122
-116,716
-9% -$2.48M 0.06% 458
2013
Q2 		$26M Buy
+1,347,838
New +$28.2M 0.06% 447

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co's HOLX Position: Q3 2018 in Review

Lord, Abbett & Co sold out of Hologic (HOLX) in Q3 2018, closing a stake of 74,700 shares — an estimated $2.97M sold.

Lord, Abbett & Co first reported a position in HOLX in Q2 2013 and held it in 9 quarters. The position peaked at $26M in Q2 2013. 445 funds tracked by Wall St. Rank hold HOLX as of Q3 2018.

  • Lord, Abbett & Co reported no remaining Hologic position as of Q3 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 74,700 Hologic shares in Q3 2018, an estimated $2.97M.
  • Lord, Abbett & Co first reported a position in Hologic in Q2 2013 and held it in 9 quarters.
  • Lord, Abbett & Co's Hologic position peaked at $26M in Q2 2013.
  • 445 funds tracked by Wall St. Rank held Hologic as of Q3 2018.

Based on Lord, Abbett & Co's 13F filing for Q3 2018, filed 14 Nov 2018.